
PROCEPT BioRobotics Corporation Common Stock
PRCT
PRCT: PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets areĀ based in the United States. Its revenue isĀ generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
moreShow PRCT Financials
Recent trades of PRCT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRCT's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Automated image-guided tissue resection and treatment Aug. 29, 2023
-
Patent Title: Minimally invasive systems with expandable supports for hemostasis in a bleeding closed tissue volume Jan. 17, 2023
-
Patent Title: Automated image-guided tissue resection and treatment Oct. 11, 2022
-
Patent Title: Physician controlled tissue resection integrated with treatment mapping of target organ images Aug. 09, 2022
-
Patent Title: Fluid jet tissue ablation apparatus Jun. 07, 2022
-
Patent Title: Water enucleation of the prostate May. 24, 2022
-
Patent Title: Method of using surgical drape Apr. 19, 2022
-
Patent Title: Minimally invasive methods for hemostasis in a bleeding closed tissue volume without occlusion Mar. 22, 2022
-
Patent Title: Surgical drape with sterile barrier Mar. 01, 2022
-
Patent Title: Tissue resection and treatment with shedding pulses Jan. 04, 2022
-
Patent Title: Apparatus for removing intact cells from a surgical site Dec. 28, 2021
-
Patent Title: Systems and methods for defining and modifying range of motion of probe used in patient treatment Aug. 24, 2021
-
Patent Title: Surgical drape with canopy Aug. 03, 2021
-
Patent Title: Surgical probes for tissue resection with robotic arms Jul. 27, 2021
-
Patent Title: Tissue sampling and catheter selection cancer treatment methods Jul. 20, 2021
-
Patent Title: Automated image-guided tissue resection and treatment May. 19, 2020
-
Patent Title: Gene analysis and generation of stem cell methods and apparatus Mar. 17, 2020
-
Patent Title: Image-guided eye surgery apparatus Jan. 07, 2020
-
Patent Title: Fluid jet tissue resection and cold coagulation methods Oct. 22, 2019
-
Patent Title: Tissue sampling, cancer detection and treatment methods Aug. 06, 2019
-
Patent Title: Cancer treatment apparatus Jul. 09, 2019
-
Patent Title: Minimally invasive methods for hemostasis in a bleeding closed tissue volume Jun. 11, 2019
-
Patent Title: Cancer detection and treatment apparatus Jan. 22, 2019
-
Patent Title: Water enucleation of the prostate Oct. 16, 2018
-
Patent Title: Prostate treatment apparatus Jul. 10, 2018
-
Patent Title: Tissue resection and treatment with shedding pulses Dec. 26, 2017
-
Patent Title: Automated image-guided tissue resection and treatment Jun. 06, 2017
-
Patent Title: Tissue resection and treatment with shedding pulses Dec. 06, 2016
-
Patent Title: Automated image-guided tissue resection and treatment Dec. 06, 2016
-
Patent Title: Automated image-guided tissue resection and treatment Jun. 14, 2016
Federal grants, loans, and purchases
Followers on PRCT's company Twitter account
Number of mentions of PRCT in WallStreetBets Daily Discussion
Recent insights relating to PRCT
Recent picks made for PRCT stock on CNBC
ETFs with the largest estimated holdings in PRCT
Flights by private jets registered to PRCT